96 related articles for article (PubMed ID: 35734930)
1. MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance.
van der Zwet JCG; Buijs-Gladdines JGCAM; Cordo' V; Debets DO; Smits WK; Chen Z; Dylus J; Zaman GJR; Altelaar M; Oshima K; Bornhauser B; Bourquin JP; Cools J; Ferrando AA; Vormoor J; Pieters R; Vormoor B; Meijerink JPP
Leukemia; 2021 Dec; 35(12):3394-3405. PubMed ID: 34007050
[TBL] [Abstract][Full Text] [Related]
2. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
Meyer LK; Huang BJ; Delgado-Martin C; Roy RP; Hechmer A; Wandler AM; Vincent TL; Fortina P; Olshen AB; Wood BL; Horton TM; Shannon KM; Teachey DT; Hermiston ML
J Clin Invest; 2020 Feb; 130(2):863-876. PubMed ID: 31687977
[TBL] [Abstract][Full Text] [Related]
4. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.
Gocho Y; Liu J; Hu J; Yang W; Dharia NV; Zhang J; Shi H; Du G; John A; Lin TN; Hunt J; Huang X; Ju B; Rowland L; Shi L; Maxwell D; Smart B; Crews KR; Yang W; Hagiwara K; Zhang Y; Roberts K; Wang H; Jabbour E; Stock W; Eisfelder B; Paietta E; Newman S; Roti G; Litzow M; Easton J; Zhang J; Peng J; Chi H; Pounds S; Relling MV; Inaba H; Zhu X; Kornblau S; Pui CH; Konopleva M; Teachey D; Mullighan CG; Stegmaier K; Evans WE; Yu J; Yang JJ
Nat Cancer; 2021 Mar; 2(3):284-299. PubMed ID: 34151288
[TBL] [Abstract][Full Text] [Related]
5. Targeting STAT5B in T-cell acute lymphoblastic leukemia.
Veloso A; Cools J
Blood; 2023 Jul; 142(3):215-217. PubMed ID: 37471110
[No Abstract] [Full Text] [Related]
6. Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.
Mansour MR; Reed C; Eisenberg AR; Tseng JC; Twizere JC; Daakour S; Yoda A; Rodig SJ; Tal N; Shochat C; Berezovskaya A; DeAngelo DJ; Sallan SE; Weinstock DM; Izraeli S; Kung AL; Kentsis A; Look AT
Br J Haematol; 2015 Jan; 168(2):230-8. PubMed ID: 25256574
[TBL] [Abstract][Full Text] [Related]
7. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
[TBL] [Abstract][Full Text] [Related]
8. A new hope for early T cell precursor acute lymphoblastic leukemia therapy based on STAT5+ leukemic stem cell targeting.
Pelayo R
J Leukoc Biol; 2023 Oct; 114(5):381-383. PubMed ID: 37607260
[TBL] [Abstract][Full Text] [Related]
9. Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia.
Oliveira ML; Veloso A; Garcia EG; Iyer S; Pereira C; Barreto VM; Langenau DM; Barata JT
Leukemia; 2022 Jun; 36(6):1533-1540. PubMed ID: 35581375
[TBL] [Abstract][Full Text] [Related]
10. PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.
Shah K; Nasimian A; Ahmed M; Al Ashiri L; Denison L; Sime W; Bendak K; Kolosenko I; Siino V; Levander F; Palm-Apergi C; Massoumi R; Lock RB; Kazi JU
Blood Cancer J; 2023 Sep; 13(1):139. PubMed ID: 37679323
[TBL] [Abstract][Full Text] [Related]
11. Venetoclax Drug Increases the Apoptosis of T and B Acute Lymphoblastic Leukemia Cells by Reducing the Expression of
Tari K; Nasimian A; Kazi JU; Abroun S
Int J Mol Cell Med; 2023; 12(3):229-241. PubMed ID: 38751657
[TBL] [Abstract][Full Text] [Related]
12. BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia.
Olesinski EA; Bhatia KS; Mahesh AN; Rosli S; Mohamed JS; Jen WY; Jain N; Garcia JS; Wong GC; Ooi M; Letai A; Konopleva M; Bhatt S
Blood Adv; 2023 Jun; 7(12):2917-2923. PubMed ID: 36763538
[No Abstract] [Full Text] [Related]
13. 1,25-OH
Pistor M; Schrewe L; Haupeltshofer S; Miclea A; Faissner S; Chan A; Hoepner R
Leuk Res Rep; 2018; 9():38-41. PubMed ID: 29892547
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of basal and IL-7-induced PI3K/Akt/mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.
Fernandes MB; Gomes AM; Oliveira ML; Caldas J; Lúcio P; Kim R; Caye-Eude A; Pereira F; De Sousa AB; De Stefano A; Follo MY; Soares MV; Lacerda JF; Desterro J; Cavé H; Clappier E; Duarte X; Ribeiro P; Barata JT
Haematologica; 2024 Apr; ():. PubMed ID: 38654666
[TBL] [Abstract][Full Text] [Related]
15. Anatomy of a crime: how IL7R and NRAS join forces to drive T-cell acute lymphoblastic leukemia.
Barata JT
Haematologica; 2024 Feb; ():. PubMed ID: 38328861
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.
Wang W; Lopez McDonald MC; Hariprasad R; Hamilton T; Frank DA
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611065
[TBL] [Abstract][Full Text] [Related]
17. Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias.
Angot L; Schneider P; Vannier JP; Abdoul-Azize S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345151
[TBL] [Abstract][Full Text] [Related]
18. Surprise, surprise: STAT5 is not enough to stop the steroids.
Fernandes MB; Barata JT
Haematologica; 2023 Mar; 108(3):670-672. PubMed ID: 35734928
[No Abstract] [Full Text] [Related]
19. STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of
Van der Zwet JCG; Cordo' V; Buijs-Gladdines JGCAM; Hagelaar R; Smits WK; Vroegindeweij E; Graus LTM; Poort V; Nulle M; Pieters R; Meijerink JPP
Haematologica; 2023 Mar; 108(3):732-746. PubMed ID: 35734930
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
